Basilea Pharmaceutica Ltd logo

Basilea Pharmaceutica Ltd (BPMUF)

Market Closed
18 Jun, 20:00
OTC PINK OTC PINK
$
60. 27
0
0%
$
846.88M Market Cap
7.96 P/E Ratio
20% Div Yield
12 Volume
2.9 Eps
$ 60.27
Previous Close
Add Transaction
Day Range
60.27 60.27
Year Range
57.7 74
Want to track BPMUF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Basilea Pharmaceutica Ltd (BPMUF) Statistics

Valuation metrics

Market Cap 846.88M
Enterprise value 694.5M
Trailing P/E (ttm) 19.36
Forward P/E -
PEG ratio -0.35
Price/Sales (ttm) 3.52
Price/Book (mrq) 4.89
Enterprise Value/Revenue 3.85
Enterprise Value/EBITDA 16.57

Overview

Shares outstanding 12.29M
Float 12.21M
Shares short -
% Held by insiders 0.01%
% Held by institutions 0.3%
Average volume (10 days) 14
Average volume (90 days) 6

Price summary

52-Week low 57.7
52-Week high 74
Beta 0.42
50-Day moving average 65.37
200-Day moving average 68.01

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 21 Jun 2013
Ex-Dividend Date 11 Apr 2013
Last split factor 1,039:1,029
Last split Date 13 Mar 2007

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025

Profitability

Profit margin 0.18%
Operating margin 0.22%

Operational effectiveness

Return on assets 0.11%
Return on equity 0.28%

Income Statement

Revenue (ttm) 294.12M
Revenue per share (ttm) 14.78
Quarterly revenue growth (yoy) -0.03%
Gross profit (ttm) 110.32M
EBITDA 51.05M
Net income to common (ttm) 50.93M
Diluted EPS (ttm) 2.65
Quarterly earnings growth (yoy) -0.57%

Balance Sheet

Total cash (mrq) 202.25M
Total cash per share (mrq) 13.3
Total debt (mrq) 112.92M
Total Debt/Equity (mrq) 0.7
Current ratio (mrq) 5.11%
Book value per share (mrq) 10.48

Cash Flow

Cash flow statement 78.59M
Levered free cash flow (LFCF) 62.22M